MYXOFIBROSARCOMA
Clinical trials for MYXOFIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare sarcoma: targeted drugs and smarter radiation on trial
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the targeted drug pazopanib (and another drug, selinexor, for high-risk patients) to standard chemotherapy and radiation can impr…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Targeted limb infusion plus immunotherapy may delay sarcoma progression
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to chemotherapy drugs (melphalan and dactinomycin) delivered directly to the affected arm or leg can safely delay cancer growth. About 30 people with advanced or spreading sarcoma in a limb will take part. The g…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:39 UTC